Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Cha

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Pharmacotherapy|February 26, 2008
In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coliRaymond Cha
Antimicrobial Agents and Chemotherapy|May 23, 2003
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic modelRaymond Cha, Michael J Rybak
Expert Review of Anti-Infective Therapy|October 16, 2004
Fluconazole for the treatment of candidiasis: 15 years experienceRaymond Cha, Jack D Sobel
The Journal of Antimicrobial Chemotherapy|October 16, 2004
Pulsatile delivery of amoxicillin against Streptococcus pneumoniaeRaymond Cha, Michael J Rybak
Diagnostic Microbiology and Infectious Disease|November 5, 2003
Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetationsRaymond Cha, Michael J Rybak
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Influence of protein binding under controlled conditions on the bactericidal activity of daptomycin in an in vitro pharmacodynamic modelRaymond Cha, Michael J Rybak
Antimicrobial Agents and Chemotherapy|July 18, 2002
In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic modelGeorge P Allen, Raymond Cha, Michael J Rybak
Pharmacotherapy|December 26, 2003
Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic modelRaymond Cha, Ronda L Akins, Michael J Rybak
Antimicrobial Agents and Chemotherapy|November 26, 2003
Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetationsRaymond Cha, William J Brown, Michael J Rybak
Journal of Medical Microbiology|December 9, 2004
Quantification and assessment of viability of Cryptococcus neoformans by LightCycler amplification of capsule gene mRNAMuhammad Amjad, Najla Kfoury, Raymond Cha, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Pharmacotherapy|February 26, 2008
In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coliRaymond Cha
Antimicrobial Agents and Chemotherapy|May 23, 2003
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic modelRaymond Cha, Michael J Rybak
Expert Review of Anti-Infective Therapy|October 16, 2004
Fluconazole for the treatment of candidiasis: 15 years experienceRaymond Cha, Jack D Sobel
The Journal of Antimicrobial Chemotherapy|October 16, 2004
Pulsatile delivery of amoxicillin against Streptococcus pneumoniaeRaymond Cha, Michael J Rybak
Diagnostic Microbiology and Infectious Disease|November 5, 2003
Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetationsRaymond Cha, Michael J Rybak
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Influence of protein binding under controlled conditions on the bactericidal activity of daptomycin in an in vitro pharmacodynamic modelRaymond Cha, Michael J Rybak
Antimicrobial Agents and Chemotherapy|July 18, 2002
In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic modelGeorge P Allen, Raymond Cha, Michael J Rybak
Pharmacotherapy|December 26, 2003
Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic modelRaymond Cha, Ronda L Akins, Michael J Rybak
Antimicrobial Agents and Chemotherapy|November 26, 2003
Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetationsRaymond Cha, William J Brown, Michael J Rybak
Journal of Medical Microbiology|December 9, 2004
Quantification and assessment of viability of Cryptococcus neoformans by LightCycler amplification of capsule gene mRNAMuhammad Amjad, Najla Kfoury, Raymond Cha, et al.
Pageof 4